Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Machteld Odijk"'
Autor:
Xiaoxia Shi, Matthew Ryan Ykema, Jaco Hazenoot, Lysbeth ten Bloemendaal, Irene Mancini, Machteld Odijk, Peter de Haan, Piter J. Bosma
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss , Pp 225-233 (2018)
Gene therapy has been shown to be a feasible approach to treat inherited disorders in vivo. Among the currently used viral vector systems, adeno-associated virus (AAV) vectors are the most advanced and have been applied in patients successfully. An i
Externí odkaz:
https://doaj.org/article/808dde88a3224fa88352b04ce933873e
Autor:
Miguel G. Toscano, Jeroen van der Velden, Sybrand van der Werf, Machteld Odijk, Ana Roque, Rafael J. Camacho-Garcia, Irene G. Herrera-Gomez, Irene Mancini, Peter de Haan
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 124-134 (2017)
Replication-defective (RD) recombinant simian virus 40 (SV40)-based gene delivery vectors hold a great potential for clinical applications because of their presumed non-immunogenicity and capacity to induce immune tolerance to the transgene products
Externí odkaz:
https://doaj.org/article/06c68bd3b6a94f5094f1b73b60f6b041
Autor:
Lysbeth ten Bloemendaal, Matthew Ryan Ykema, Machteld Odijk, Piter J. Bosma, Jaco Hazenoot, Xiaoxia Shi, Irene Mancini, Peter de Haan
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss, Pp 225-233 (2018)
Molecular therapy. Methods & clinical development, 9, 225-233. Nature Publishing Group
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss, Pp 225-233 (2018)
Molecular therapy. Methods & clinical development, 9, 225-233. Nature Publishing Group
Gene therapy has been shown to be a feasible approach to treat inherited disorders in vivo. Among the currently used viral vector systems, adeno-associated virus (AAV) vectors are the most advanced and have been applied in patients successfully. An i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecfa69d8906048218236b46006c5a6c0
http://europepmc.org/articles/PMC5948228
http://europepmc.org/articles/PMC5948228
Publikováno v:
Crustaceana. 90:1099-1115
A new sponge-associated species, Paraclimenaeus michaeli sp. nov. from Sulawesi, Indonesia, and Singapore, is described and illustrated. The new species can be distinguished from its congenerics by: (1) the downwards curved rostrum with 2 acute dorsa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9da687472802694dff121e501eaf16bd
https://doi.org/10.1163/15685403-00003660
https://doi.org/10.1163/15685403-00003660
Autor:
Jeroen van der Velden, Rafael J. Camacho-Garcia, Irene G. Herrera-Gomez, Peter de Haan, Machteld Odijk, Sybrand van der Werf, Irene Mancini, Ana Roque, Miguel G. Toscano
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 124-134 (2017)
Molecular Therapy. Methods & Clinical Development
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 124-134 (2017)
Molecular Therapy. Methods & Clinical Development
idUS. Depósito de Investigación de la Universidad de Sevilla
Toscano, Miguel G. et al.
Replication-defective (RD) recombinant simian virus 40 (SV40)-based gene delivery vectors hold a great potential for clinical applications because of their presumed non-immunogenicity and capacity to induce immune toler
Replication-defective (RD) recombinant simian virus 40 (SV40)-based gene delivery vectors hold a great potential for clinical applications because of their presumed non-immunogenicity and capacity to induce immune toler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e61303e0859567cfa486e425c7fdff7
http://hdl.handle.net/10261/165539
http://hdl.handle.net/10261/165539
